Search

Your search keyword '"Agraz, Irene"' showing total 198 results

Search Constraints

Start Over You searched for: Author "Agraz, Irene" Remove constraint Author: "Agraz, Irene"
198 results on '"Agraz, Irene"'

Search Results

2. Ex vivo C5b-9 Deposition Test to Monitor Complement Activity in Clinical and Subclinical Atypical Hemolytic Uremic Syndrome and in Transplantation-Associated Thrombotic Microangiopathy

4. Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial

5. Ex vivo C5b-9 deposition test to monitor complement activity in clinical and subclinical aHUS and in transplantation-associated thrombotic microangiopathy (TA-TMA)

8. Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis

9. Predictors of outcome in a Spanish cohort of patients with Fabry disease on enzyme replacement therapy

10. The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy

11. Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring

15. Sequential Treatment with Tacrolimus and Rituximab vs. Alternating Corticosteroids and Cyclophosphamide in Primary Membranous Nephropathy (PMN): FR-OR53

16. The coexistence of diabetic retinopathy and diabetic nephropathy is associated with worse kidney outcomes.

17. Epidemiology of Immune-Mediated Glomerulopathies before and after SARS-CoV-2 Vaccination: A Tertiary Referral Hospital Experience

18. Estudio Piloto De Seguimiento En Pacientes Con Enfermedad Renal Diabética Mediante La Aplicación Nora

19. The Presence of ANCA in IgA Crescentic Nephropathy Does Not Lead to Worse Prognosis with Intensive Rescue Treatment

21. MO073: Ex Vivo C5B9 Deposition Test as a Diagnostic and Monitoring Tool For Primary and Transplantation Associated AHUS

22. MO009: Creatine-Kinase Elevation in Autosomal Dominant Polycystic Kidney Disease Patients on Tolvaptan Treatment

23. MO154: Enteric Budesonide in IGAN Nephropathy: A Real World Clinical Practice

25. Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?

27. Safety of Obtaining an Extra Biobank Kidney Biopsy Core

28. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

35. Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus

36. Antimyeloperoxidase and proteinase 3 antibodies for nephritis flare prediction in ANCA-associated-vasculitis

37. Predictores de eventos clínicos en una cohorte de pacientes con enfermedad de Fabry en tratamiento sustitutivo enzimático

39. A Specific Tubular ApoA-I Distribution Is Associated to FSGS Recurrence after Kidney Transplantation

40. MO298A SPECIFIC TUBULAR APOA-I DISTRIBUTION IS ASSOCIATED TO FSGS RECURRENCE AFTER KIDNEY TRANSPLANTATION

42. MO151CLINICAL COURSE AND OUTCOMES OF COVID-19 PATIENTS WITH BIOPSY-PROVEN GLOMERULAR AND TUBULAR KIDNEY DISEASE. LOW HEMOGLOBIN LEVELS AS A RISK FACTOR FOR MORTALITY

44. MO160COVID-19 INFECTION AND ACUTE TUBULOINTERSTITIAL NEPHRITIS

45. MO141ACUTE KIDNEY INJURY AS A RISK FACTOR FOR MORTALITY IN ONCOLOGICAL PATIENTS RECEIVING CHECK-POINT INHIBITORS

46. MO308COULD THE PRESENCE OF ANCAS IN IGA NEPHROPATHY WITH CRESCENTS HAVE A CLINICAL IMPLICATION?

47. The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy

48. Acute kidney injury as a risk factor for mortality in oncological patients receiving checkpoint inhibitors.

49. Anti-myeloperoxidase and proteinase 3 antibodies for nephritis flare prediction in anti-neutrophil cytoplasmic antibody–associated vasculitis.

50. Acute kidney injury as a risk factor for mortality in oncological patients receiving checkpoint inhibitors

Catalog

Books, media, physical & digital resources